Biomea Fusion, Inc. (BMEA)
NASDAQ
Market Cap
$159.95M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
302 of 809
Rank in Industry
177 of 445
Largest Insider Buys in Sector
BMEA Stock Price History Chart
BMEA Stock Performance
About Biomea Fusion, Inc.
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.
Insider Activity of Biomea Fusion, Inc.
Over the last 12 months, insiders at Biomea Fusion, Inc. have bought $55,361 and sold $0 worth of Biomea Fusion, Inc. stock.
On average, over the past 5 years, insiders at Biomea Fusion, Inc. have bought $8.26M and sold $13.28M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Valle Franco (Chief Financial Officer) — $55,361.
The last purchase of 12,509 shares for transaction amount of $55,361 was made by Valle Franco (Chief Financial Officer) on 2024‑06‑11.
List of Insider Buy and Sell Transactions, Biomea Fusion, Inc.
| 2024-06-11 | Valle Franco | Chief Financial Officer | 12,509 0.0348% | $4.43 | $55,361 | +17.61% | ||
| 2023-06-01 | Sale | A2A Pharmaceuticals, Inc. | 10 percent owner | 50,000 0.1638% | $34.56 | $1.73M | -57.40% | |
| 2023-05-31 | Sale | A2A Pharmaceuticals, Inc. | 10 percent owner | 75,000 0.2524% | $33.81 | $2.54M | -55.18% | |
| 2023-05-12 | Sale | A2A Pharmaceuticals, Inc. | 10 percent owner | 25,000 0.0841% | $33.84 | $846,000 | -53.60% | |
| 2023-05-09 | Sale | A2A Pharmaceuticals, Inc. | 10 percent owner | 150,000 0.5185% | $34.50 | $5.18M | -53.17% | |
| 2023-05-08 | Sale | A2A Pharmaceuticals, Inc. | 10 percent owner | 100,000 0.3445% | $33.99 | $3.4M | -52.59% | |
| 2023-04-20 | Sale | A2A Pharmaceuticals, Inc. | 10 percent owner | 200,000 0.6723% | $29.12 | $5.82M | -43.70% | |
| 2023-03-31 | Sale | A2A Pharmaceuticals, Inc. | 10 percent owner | 200,000 0.6812% | $31.25 | $6.25M | -45.44% | |
| 2023-03-30 | Chen Bihua | 400,000 1.2695% | $30.00 | $12M | -47.04% | |||
| 2022-11-14 | Hitchcock Michael J.M. | director | 5,000 0.0169% | $7.93 | $39,650 | +88.46% | ||
| 2022-11-11 | Valle Franco | Chief Financial Officer | 4,100 0.0134% | $7.63 | $31,286 | +90.01% | ||
| 2022-08-16 | A2A Pharmaceuticals, Inc. | 30,684 0.1067% | $13.87 | $425,648 | -9.74% | |||
| 2022-07-21 | Sale | A2A Pharmaceuticals, Inc. | 34,658 0.1118% | $11.21 | $388,516 | -2.11% | ||
| 2022-06-24 | Sale | A2A Pharmaceuticals, Inc. | 34,658 0.1168% | $11.76 | $407,578 | -5.69% | ||
| 2022-01-14 | Valle Franco | Chief Financial Officer | 10,000 0.033% | $8.68 | $86,767 | -17.39% | ||
| 2021-09-17 | Stergiopoulos Sotirios | director | 34,658 0.1193% | $10.96 | $379,852 | -20.13% | ||
| 2021-09-17 | A2A Pharmaceuticals, Inc. | 10 percent owner | 34,658 0.1193% | $10.96 | $379,852 | -20.13% | ||
| 2021-08-23 | Erdtmann Rainer M | President & COO | 24,000 0.0831% | $13.20 | $316,872 | -32.89% | ||
| 2021-08-23 | Butler Thomas Andrew | CEO | 24,000 0.0831% | $13.20 | $316,872 | -32.89% | ||
| 2021-08-18 | Erdtmann Rainer M | President & COO | 14,000 0.0486% | $10.77 | $150,738 | -17.52% |
Insider Historical Profitability
<0.0001%
| Valle Franco | Chief Financial Officer | 42500 0.0492% | $4.45 | 3 | 0 | +36.31% |
| Stergiopoulos Sotirios | director | 4400000 12.429% | $4.45 | 1 | 0 | <0.0001% |
| Chen Bihua | 3570872 10.0869% | $4.45 | 2 | 0 | <0.0001% | |
| A2A Pharmaceuticals, Inc. | 10 percent owner | 3500000 9.8867% | $4.45 | 2 | 9 | <0.0001% |
| Erdtmann Rainer M | President & COO | 228470 0.6454% | $4.45 | 4 | 0 | <0.0001% |
| Butler Thomas Andrew | CEO | 228470 0.6454% | $4.45 | 4 | 0 | <0.0001% |
| Hitchcock Michael J.M. | director | 5000 0.0141% | $4.45 | 1 | 0 | +88.46% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Fidelity Investments | $80.07M | 14.9 | 5.36M | 0% | +$0 | 0.01 | |
| State Street | $67.06M | 12.48 | 4.49M | +232.03% | +$46.86M | <0.01 | |
| Cormorant Asset Management Lp | $53.38M | 9.93 | 3.57M | 0% | +$0 | 2.53 | |
| Laurion Capital Management LP | $40.68M | 7.57 | 2.72M | -0.56% | -$229,990.80 | 1.14 | |
| Baker Bros Advisors LP | $31.53M | 5.87 | 2.11M | 0% | +$0 | 0.4 | |
| BlackRock | $29.5M | 5.49 | 1.97M | -8.48% | -$2.73M | <0.01 | |
| The Vanguard Group | $20.42M | 3.8 | 1.37M | +1.16% | +$233,608.70 | <0.0001 | |
| Janus Henderson | $19.21M | 3.58 | 1.29M | -25.2% | -$6.47M | 0.01 | |
| Driehaus Capital Management LLC | $17.85M | 3.32 | 1.19M | +0.95% | +$167,619.40 | 0.18 | |
| Aisling Capital Management LP | $11.94M | 2.22 | 798,757 | 0% | +$0 | 4.09 | |
| Geode Capital Management | $7.38M | 1.37 | 493,631 | +2.77% | +$199,003.97 | <0.01 | |
| Rafferty Asset Management Llc | $7.15M | 1.33 | 478,367 | +370.47% | +$5.63M | 0.02 | |
| Woodline Partners LP | $6.95M | 1.29 | 464,573 | 0% | +$0 | 0.07 | |
| Morgan Stanley | $6.84M | 1.27 | 457,421 | -4.39% | -$313,666.41 | <0.01 | |
| Citigroup | $6.12M | 1.14 | 409,558 | +669.95% | +$5.33M | 0.01 | |
| Goldman Sachs | $5.2M | 0.97 | 347,964 | +102.44% | +$2.63M | <0.01 | |
| Bank of America | $4.57M | 0.85 | 305,953 | +178.92% | +$2.93M | <0.0001 | |
| Susquehanna International Group | $4.3M | 0.8 | 287,864 | +233% | +$3.01M | 0.01 | |
| UBS | $3.95M | 0.74 | 264,199 | +260.38% | +$2.85M | <0.01 | |
| Northern Trust | $3.24M | 0.6 | 216,444 | -2.67% | -$88,623.60 | <0.01 | |
| ROCK SPRINGS CAPITAL MANAGEMENT, LP | $2.71M | 0.5 | 181,147 | 0% | +$0 | 0.07 | |
| Charles Schwab | $2.68M | 0.5 | 178,935 | +1.21% | +$31,963.10 | <0.01 | |
| T. Rowe Price | $2.66M | 0.49 | 177,602 | +0.58% | +$15,373.52 | <0.0001 | |
| Deutsche Bank | $2.57M | 0.48 | 171,763 | +0.19% | +$4,978.35 | <0.01 | |
| Wellington Management Company | $1.53M | 0.29 | 102,534 | +19.87% | +$254,120.22 | <0.0001 | |
| OZ MANAGEMENT LLC | $1.42M | 0.27 | 95,100 | New | +$1.42M | 0.02 | |
| Dimensional Fund Advisors | $1.34M | 0.25 | 89,865 | 0% | +$0 | <0.0001 | |
| Arrowmark Colorado Holdings Llc | $1.14M | 0.21 | 76,285 | 0% | +$0 | <0.01 | |
| Prosight Management Lp | $1.12M | 0.21 | 75,000 | +74.45% | +$478,534.55 | 0.31 | |
| Profund Advisors Llc | $1.09M | 0.2 | 72,877 | +340.96% | +$842,432.38 | 0.03 | |
| BNY Mellon | $955,563.00 | 0.18 | 63,917 | -10.31% | -$109,853.04 | <0.0001 | |
| Millennium Management LLC | $893,816.00 | 0.17 | 59,787 | -61.69% | -$1.44M | <0.01 | |
| Nuveen | $825,002.00 | 0.15 | 55,184 | 0% | +$0 | <0.0001 | |
| LINSCO PRIVATE LEDGER CORP | $814,312.00 | 0.15 | 54,469 | +69.68% | +$334,401.78 | <0.0001 | |
| Citadel Advisors LLC | $800,513.00 | 0.15 | 53,546 | New | +$800,513.00 | <0.01 | |
| Wexford Capital, LLC | $706,821.00 | 0.13 | 47,279 | New | +$706,821.00 | 0.15 | |
| Barclays | $699,000.00 | 0.13 | 46,817 | -35.22% | -$379,995.49 | <0.0001 | |
| Swiss National Bank | $683,215.00 | 0.13 | 45,700 | 0% | +$0 | <0.0001 | |
| Marshall Wace | $636,452.00 | 0.12 | 42,572 | -82.23% | -$2.94M | <0.01 | |
| Nan Fung Group | $598,000.00 | 0.11 | 40,000 | 0% | +$0 | 0.65 | |
| Griffin Asset Management Inc | $566,455.00 | 0.11 | 37,890 | +39.35% | +$159,964.86 | 0.07 | |
| Jane Street Capital | $541,459.00 | 0.1 | 36,218 | -88.56% | -$4.19M | <0.01 | |
| Artia Global Partners Lp | $530,007.00 | 0.1 | 35,452 | +39.29% | +$149,499.89 | 0.13 | |
| Gsa Capital Partners Llp | $530,000.00 | 0.1 | 35,444 | -33.37% | -$265,418.69 | 0.04 | |
| Two Sigma | $499,345.00 | 0.09 | 33,401 | -75.84% | -$1.57M | <0.01 | |
| Connor Clark & Lunn Investment Management Ltd | $459,683.00 | 0.09 | 30,748 | -15.28% | -$82,912.77 | <0.01 | |
| SG Americas Securities, LLC | $462,000.00 | 0.09 | 30,924 | New | +$462,000.00 | <0.01 | |
| Afg Fiduciary Services Limited Partnership | $373,466.00 | 0.08 | 29,177 | New | +$373,466.00 | <0.01 | |
| AllianceBernstein | $435,643.00 | 0.08 | 29,140 | 0% | +$0 | <0.0001 | |
| RhumbLine Advisers | $418,083.00 | 0.08 | 27,966 | +2.22% | +$9,089.41 | <0.0001 |